# Human Mass Balance Study of Pyronaridine

> **NCT01383109** · PHASE1 · COMPLETED · sponsor: **Medicines for Malaria Venture** · enrollment: 6 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** 14C-labeled Pyronaridine

## Key facts

- **NCT ID:** NCT01383109
- **Lead sponsor:** Medicines for Malaria Venture
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01383109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01383109, "Human Mass Balance Study of Pyronaridine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01383109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*